Genoss Co., Ltd.

This study follows 300 people with blocked leg arteries who received a treatment using a balloon coated with paclitaxel and vitamin E. The goal is to see if the balloon keeps the artery open and prevents the need for repeat procedures over one year. Participants are adults with m…

This study is tracking 200 people with blocked leg arteries who are receiving a special balloon coated with the drug paclitaxel (GENOSS PCB). The balloon is inflated inside the artery to open it and release the drug, which helps prevent the artery from narrowing again. Researcher…

This study looks at how well the GENOSS stent works in real-world patients who have had a heart attack or unstable chest pain (acute coronary syndrome). Researchers are tracking heart-related events like death, heart attacks, and the need for repeat procedures. The study involves…

This study is testing a new type of stent (a small mesh tube) coated with a drug that slowly releases to keep heart arteries open. The stent uses a special coating that dissolves over time, which may reduce long-term risks. About 1,000 adults with coronary artery disease who need…

This study is tracking 1000 adults with multivessel coronary artery disease who received a special drug-coated stent called GENOSS® DES. The stent slowly releases sirolimus to help prevent the artery from narrowing again. Researchers are monitoring safety and effectiveness over t…

This study is tracking over 1,100 people with coronary artery disease who received the GENOSS SES stent, a device that props open blocked heart arteries. Researchers are monitoring heart-related deaths, heart attacks, and the need for repeat procedures over time. The goal is to s…

This study compares a new drug-coated balloon (Genoss SCB) to an existing one (SeQuent Please NEO) for treating coronary arteries that have re-narrowed after stenting. About 94 adults with this condition will be randomly assigned to receive one of the two balloons during a standa…

This study is testing a special balloon coated with a drug (paclitaxel) and natural substances (shellac and vitamin E) to treat small coronary artery disease. The balloon is inflated inside the narrowed artery to deliver the drug and help keep it open. Researchers will follow 3,0…